But with reams of data on the drugs' health benefits beyond reducing obesity—including mitigating heart disease, diabetes, chronic kidney disease, and sleep apnea—most seem to have finally accepted their potentially immense societal value.
Now comes the hard part. These highly effective drugs—GLP-1s—are changing the way obesity is viewed and treated. The changes are coming so fast and could benefit so many that they've created new questions and ethical quandaries for medical professionals, including who should get them.
The theoretical market for Wegovy and Zepbound is massive: The Food and Drug Administration approved them for anyone with a body-mass index of 30 or more—27 or higher for individuals with a weight-related condition like high blood pressure or sleep apnea. Some 57 million working-age Americans with private insurance match those criteria, as do nearly 14 million retirement-age Americans. The expectation is that once started, the drugs will need to be taken for life to maintain the results.
Bu hikaye Financial Express Chennai dergisinin December 26, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Financial Express Chennai dergisinin December 26, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Tenuous Gaza ceasefire
A permanent cessation of hostilities to facilitate reconstruction, however, is an open question
Inflection point
GenAI has unlocked a new dimension of efficiency & innovation
Analysts Remain Bullish on Zomato Despite Share Dip
Expect sustainable growth profitability in the coming years
DPDP Act will be outdated before it's passed
The Act targets entities which are complex adaptive platforms that have embedded AI in their processes. To expect them to adhere to static regulations is a mistake
Birthright Citizenship to End, Will Impact Indian Americans
STARTING HIS SECOND term with a flurry of executive orders, US President Donald Trump has sought to revoke birthright citizenship - automatic citizenship of children born in the US to non-citizen parents.
OpenAI CFO: Musk shouldn't use legal challenges to compete
OPENAI CHIEF FINANCIAL Officer (CFO) Sarah Friar characterized Elon Musk's legal challenge to stop the ChatGPT maker from becoming a for-profit company as competitive maneuvering.
Job market in India needs a boost in FY26 Budget: Rajan
Former RBI Governor Raghuram Rajan has lauded the Narendra Modi government for doing a lot of good work on infrastructure and hoped there would be some concrete steps in the Budget to boost the job market.
Tech sector's talent model seen evolving: Infosys CTO
INFOSYS EXPECTS THE way the tech industry manages talent to shift and has already begun experimenting with how this transformation will occur, its chief technology officer Rafee Tarafdar said in an interview.
EU wants to bolster strategic India tie-up
India to enter new era in 2028, says Andhra CM Naidu INDIA WILL ENTER a new era of global leadership starting in 2028, Andhra Pradesh chief minister said on Tuesday at a CII session on the sidelines of the WEF meeting. \"From 2028, it is going to be the era of India. That is bound to happen. It will be the only country with a demographic dividend for another 20-25 years,\" he said. - PTI
Exporters Can Import Small Diamonds Sans Duty From Apr 1
THE GOVERNMENT ON Tuesday announced a scheme that will allow duty-free import of natural cut and polished diamonds of up to 25 cents or quarter of a carat by exporters to retain India's position as a global leader in the entire diamond value chain, according to a statement.
